Metformin EP Impurity D

Metformin EP Impurity D is a structurally related degradation byproduct of Metformin, characterized by a substituted biguanide core with a methylamino group and an additional nitrogen-containing functional group. Its molecular architecture features a trimeric guanidine motif, differing from the parent drug by the absence of a dimethylamino substituent and the presence of a secondary amine linkage. This impurity arises via non-enzymatic amidation pathways during Metformin synthesis or storage. It serves as a critical HPLC reference standard for quantifying process-related impurities in Metformin active pharmaceutical ingredients.